Hormone therapy is widely used to treat menopausal symptoms such as hot flashes and night sweats. But scientists have long ...
We want to not only push toward a dementia care strategy in B.C., but we would want to incorporate this brain health clinic ...
Health and Me on MSN
Weight loss drug semaglutide cannot slow down Alzheimer’s: Lancet study
Evoke and Evoke+ -- the randomized, double-blind, placebo-controlled phase 3 trials conducted across 566 sites in 40 ...
The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...
Eye imaging may help distinguish ALS from Alzheimer’s disease by revealing differences in retinal protein deposits using polarized light.
EatingWell on MSN
You just found out that you’re at risk for dementia—here’s what experts say to do first
Small actions today can help reduce your dementia risk.
GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...
New analyses show DLB patients with lower plasma pTau181 levels — indicating an earlier stage of disease and absence of Alzheimer’s disease (AD) ...
A morning cup of coffee or tea may do more than just helping you wake up and start the day, according to major study of ...
This review argues that women’s higher Alzheimer disease risk may be shaped in part by midlife neuroendocrine aging, ...
A new Duke study is exploring whether cells inside the nose could reveal early signs of Alzheimer’s disease. Researchers say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results